Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full ...
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemons ...
The U.S. Food and Drug Administration (FDA) issued new draft guidance on October 29, 2025, proposing what it said were “major updates to ...
There’s a growing push to use AI to teach faster. These tools are fast, but shallow. They fail to capture the nuance, care and complexity that deep learning demands.
When it comes to promotion and tenure, don’t just describe your research—explain and quantify its impact.
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...